We retrospectively applied the proposed diagnostic criteria to a monocentric cohort of patients with borderline and positive results for MOG‐IgG as detected in clinical practice in order to critically evaluate the likelihood of MOG‐EM vs MS. The gene discussed is MOG; the disease is myeloid sarcoma.